Targeted inhibition of HK-II reversed the warburg effect to improve the radiosensitivity of laryngeal carcinoma

XH Chen, DL Yu, JT Zhong, SH Zhou… - Cancer Management …, 2021 - Taylor & Francis
Purpose Hexokinase-II (HK-II) is the key enzyme in the first rate-limiting step of glycolysis
that catalyzes the conversion of glucose to glucose-6-phosphate. Here, we examined the …
被引用次数：4 相关文章

Targeted Inhibition of HK-II Reversed the Warburg Effect to Improve the Radiosensitivity of Laryngeal Carcinoma

C Xiao-Hong, Y Ding-Li, Z Jiang-Tao… - Cancer …, 2021 - search.proquest.com
Purpose: Hexokinase-II (HK-II) is the key enzyme in the first rate-limiting step of glycolysis
that catalyzes the conversion of glucose to glucose-6-phosphate. Here, we examined the …

Targeted Inhibition of HK-II Reversed the Warburg Effect to Improve the Radiosensitivity of Laryngeal Carcinoma

XH Chen, DL Yu, JT Zhong… - Cancer …, 2021 - pubmed.ncbi.nlm.nih.gov
Purpose Hexokinase-II (HK-II) is the key enzyme in the first rate-limiting step of glycolysis
that catalyzes the conversion of glucose to glucose-6-phosphate. Here, we examined the …

Targeted Inhibition of HK-II Reversed the Warburg Effect to Improve the Radiosensitivity of Laryngeal Carcinoma

XH Chen, DL Yu, JT Zhong, SH Zhou… - Cancer Management …, 2021 - dovepress.com
Purpose: Hexokinase-II (HK-II) is the key enzyme in the first rate-limiting step of glycolysis
that catalyzes the conversion of glucose to glucose-6-phosphate. Here, we examined the …
[HTML] nih.gov

[HTML][HTML] Targeted Inhibition of HK-II Reversed the Warburg Effect to Improve the Radiosensitivity of Laryngeal Carcinoma

XH Chen, DL Yu, JT Zhong, SH Zhou… - Cancer Management …, 2021 - ncbi.nlm.nih.gov
Purpose Hexokinase-II (HK-II) is the key enzyme in the first rate-limiting step of glycolysis
that catalyzes the conversion of glucose to glucose-6-phosphate. Here, we examined the …

Targeted Inhibition of HK-II Reversed the Warburg Effect to Improve the Radiosensitivity of Laryngeal Carcinoma.

XH Chen, DL Yu, JT Zhong, SH Zhou… - Cancer Management …, 2021 - europepmc.org
Purpose Hexokinase-II (HK-II) is the key enzyme in the first rate-limiting step of glycolysis
that catalyzes the conversion of glucose to glucose-6-phosphate. Here, we examined the …

Targeted Inhibition of HK-II Reversed the Warburg Effect to Improve the Radiosensitivity of Laryngeal Carcinoma

XH Chen, DL Yu, JT Zhong, SH Zhou… - Cancer Management …, 2021 - dovepress.com
Purpose: Hexokinase-II (HK-II) is the key enzyme in the first rate-limiting step of glycolysis
that catalyzes the conversion of glucose to glucose-6-phosphate. Here, we examined the …